Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedApr 25, 2018Lipoic Acid 25mg/mLLack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.Partell Specialty Pharmacy · D-0640-2018Class IITerminatedApr 25, 2018HCG 1000 units/mLLack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.Partell Specialty Pharmacy · D-0639-2018Class IITerminatedApr 25, 2018Glutathione 200mg/mLLack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.Partell Specialty Pharmacy · D-0638-2018Class IITerminatedApr 25, 2018CoEnzymeQ10 25mg/mLLack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.Partell Specialty Pharmacy · D-0637-2018Class IITerminatedApr 25, 2018Biotin Suspension 10mg/mLLack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.Partell Specialty Pharmacy · D-0636-2018Class IITerminatedApr 25, 2018B-complexLack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.Partell Specialty Pharmacy · D-0635-2018Class IITerminatedApr 25, 2018Ascorbic AcidLack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.Partell Specialty Pharmacy · D-0634-2018Class IITerminatedApr 25, 2018Amantadine HCl CapsulesFailed Dissolution SpecificationsAVKARE Inc. · D-0633-2018Class IIITerminatedApr 25, 2018Vasopressin 50 Units added to 250 mL 0.9% Sodium Chloride Injection USPcGMP deviationsPharmedium Services, LLC · D-0632-2018Class IIITerminatedApr 25, 2018Triamterene and Hydrochlorothiazide TabletsCross Contamination With Other Products: presence of unrelated ingredients (i.e. traces of Lisinopril, Mannitol, Iron, Calcium and Phosphorous).Sandoz Incorporated · D-0631-2018Class IITerminatedApr 25, 2018WipeEssentials Wet WipesCGMP Deviations: finished products were manufactured with poor quality water.Diamond Wipes International, Inc. · D-0630-2018Class IITerminatedApr 25, 2018ACURE, clarifying acneCGMP Deviations: finished products were manufactured with poor quality water.Diamond Wipes International, Inc. · D-0629-2018Class IITerminatedApr 25, 2018PASTA DE LASSAR ANDROMACO Skin ProtectionMicrobial Contamination of Non-Sterile ProductsMarcas Usa Llc · D-0628-2018Class IITerminatedApr 25, 2018DaytranaDefective Delivery System: Out of specification for adhesive transfer.Noven Pharmaceuticals, Inc. · D-0627-2018Class IIITerminatedApr 18, 2018Decitabine for InjectionFailed impurities/degradation specifications: Failure to water content and impurityInvaGen Pharmaceuticals, Inc. · D-0698-2018Class IIITerminatedApr 18, 2018Tramadol Hydrochloride 50 mg tabletsLabeling: Incorrect or Missing Lot and/or Exp DateLake Erie Medical & Surgical Supply Inc · D-0626-2018Class IITerminatedApr 18, 2018Zhong Hua JiuCGMP Deviations: the product was produced with substandard GMP manufacturing processes.United Pacific Co Ltd · D-0624-2018Class IITerminatedApr 18, 2018ConzerolcGMP DeviationsElroselabs Inc. · D-0623-2018Class IITerminatedApr 18, 2018MolleavecGMP DeviationsElroselabs Inc. · D-0622-2018Class IITerminatedApr 18, 2018Conzerol zero molluscum contagiosumcGMP DeviationsElroselabs Inc. · D-0621-2018Class IIITerminatedApr 11, 2018buPROPion HCl Extended-Release TabletsFailed Dissolution Specifications; during stability testingInvaGen Pharmaceuticals, Inc. · D-0619-2018Class IIITerminatedApr 11, 2018buPROPion HCl Extended-Release TabletsFailed Dissolution Specifications; during stability testingInvaGen Pharmaceuticals, Inc. · D-0618-2018Class IIITerminatedApr 11, 2018Fabior (tazarotene) FoamSuperpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.Mayne Pharma Inc · D-0616-2018Class ITerminatedApr 4, 2018Red Zone Xtreme 3000 CapsulesMarketed without an Approved NDA/ANDA; FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction.Jimmy Weber · D-0625-2018Class IITerminatedApr 4, 2018Vancomycin 1.25g added to 250 mL of 0.9% Sodium Chloride IV bagStability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.Apollo Care · D-0615-2018Class IITerminatedApr 4, 2018Vancomycin 1g added to 250mL of 0.9% Sodium Chloride IV bagStability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.Apollo Care · D-0614-2018Class IIITerminatedApr 4, 201824-HOUR Oral Care q4 Kit with Ballard* TechnologySubpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.Akorn, Inc. · D-0613-2018Class IIITerminatedApr 4, 201824-HOUR Oral Care q2 Kit with Ballard* TechnologySubpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.Akorn, Inc. · D-0612-2018Class IIITerminatedApr 4, 2018Chlorhexidine Gluconate Oral RinseSubpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.Akorn, Inc. · D-0611-2018Class IITerminatedApr 4, 2018Fosphenytoin Sodium InjectionPresence of particulate matterAmneal Pharmaceuticals · D-0610-2018Class IITerminatedApr 4, 2018E-Z-Paste Barium Sulfate Esophageal CreamFailed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.Bracco Diagnostics Inc. · D-0609-2018Class IITerminatedApr 4, 2018EvamistDefective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense...Paddock Laboratories, LLC. · D-0608-2018Class IIITerminatedApr 4, 2018Indomethacin Capsules USPLabeling: Incorrect Instructions: bottles incorrectly labeled with the usual adult dosage of "One or two capsules 2 or 3 times a day." rather than the correct usual...Glenmark Pharmaceuticals Inc., USA · D-0606-2018Class IIITerminatedApr 4, 2018Flucanazole InjectionSuperpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeabilityRenaissance Lakewood, LLC · D-0605-2018Class IITerminatedMar 28, 2018Estradiol Vaginal InsertsDefective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.Teva Pharmaceuticals USA · D-0620-2018Class IIITerminatedMar 28, 2018Triamcinolone Acetonide LotionFailed Impurities/Degradation Specifications: High out of specification results for an impurity.Akorn, Inc. · D-0617-2018Class IIITerminatedMar 28, 2018Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355...Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.Pine Pharmaceuticals, LLC · D-0607-2018Class IITerminatedMar 28, 2018DELFLEX Peritoneal Dialysis SolutionLack of Assurance of Sterility: Leakage of the peritoneal dialysis (PD) solution bag.Fresenius Medical Care Renal Therapies Group, LLC · D-0604-2018Class IITerminatedMar 21, 2018Valacyclovir Tablets USP 1 gramTemperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same...Hetero Labs Limited Unit V · D-0602-2018Class IITerminatedMar 21, 2018Valganciclovir TabletsTemperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same...Hetero Labs Limited Unit V · D-0601-2018